← Back to Search

Repetitive Transcranial Magnetic Stimulation

Dash Protocol for Depression (Comfort Start Trial)

N/A
Waitlist Available
Research Sponsored by Neuronetics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Awards & highlights

Summary

This trial will compare the standard NeuroStar TMS protocol with a new feature that alters the strength of the pulses, in order to find which is more comfortable for patients.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate comfort of TMS treatment
Secondary outcome measures
Ability to reach prescribed treatment intensity

Trial Design

2Treatment groups
Active Control
Group I: Dash ProtocolActive Control1 Intervention
Patients will be randomized after consent to receive standard Dash protocol
Group II: Modified Dash protocol with the New feature enabledActive Control1 Intervention
Patients will be randomized after consent to receive modified Dash protocol with the New feature enabled

Find a Location

Who is running the clinical trial?

NeuroneticsLead Sponsor
23 Previous Clinical Trials
7,542 Total Patients Enrolled
12 Trials studying Depression
7,087 Patients Enrolled for Depression
Steve A Erickson, BSStudy DirectorNeuronetics

Media Library

NeuroStar New Treatment Feature (Repetitive Transcranial Magnetic Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05535062 — N/A
Depression Research Study Groups: Dash Protocol, Modified Dash protocol with the New feature enabled
Depression Clinical Trial 2023: NeuroStar New Treatment Feature Highlights & Side Effects. Trial Name: NCT05535062 — N/A
NeuroStar New Treatment Feature (Repetitive Transcranial Magnetic Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05535062 — N/A
~15 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top